India’s Bioeconomy has surged from roughly **$10 bn in 2014** to **$195 bn in 2025**, registering an annual growth of **17‑18 %**. Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh, highlighted this expansion at the 14th Foundation Day of BIRAC, underscoring the sector’s role in healthcare, agriculture, climate mitigation and sustainable manufacturing.
Key Developments
- Target of $300 bn by 2030 – The government aims to reach this milestone through a robust ecosystem of scientists, entrepreneurs and policy support.
- BioE3 Policy launch – The BioE3 Policy will boost precision biotherapeutics, smart proteins, climate‑resilient crops, bio‑based chemicals and carbon‑capture technologies.
- RDI Fund allocation – A dedicated RDI Fund of **₹1 lakh crore** places BIRAC at the centre of scaling biotech ventures.
- Infrastructure push – Creation of shared bio‑foundries, Bio‑AI hubs and advanced biomanufacturing platforms.
- Startup ecosystem – Over **11,800 biotech startups** are now active, driving innovation and job creation.
Important Facts
- The India Bioeconomy Report (IBER) 2026 records a **CAGR of ~18 %** since 2020.
- The sector contributes **4.8 % of national GDP** (≈$195.3 bn) and has more than **doubled in size** since 2020.
- Key focus areas under BioE3 include precision biotherapeutics, smart proteins, climate‑resilient agriculture, bio‑based chemicals and carbon capture.
- Government funding and mentorship have led to commercialization of affordable healthcare solutions and sustainable technologies.
Exam Relevance
The rapid expansion of the Bioeconomy touches multiple GS papers. For GS‑III (Economy) it illustrates a high‑growth sector contributing to GDP, employment and export potential. For GS‑II (Polity) the role of ministries, BIRAC and policy instruments like the BioE3 Policy demonstrate governance for innovation. For GS‑IV (Ethics) the emphasis on inclusive talent development, especially from tier‑2/3 cities and women entrepreneurs, aligns with equitable growth objectives.
Way Forward
- Strengthen public‑private partnerships to accelerate scale‑up of promising biotech products.
- Expand shared infrastructure like bio‑foundries across regions to reduce geographic disparity.
- Enhance skill development programmes targeting youth in tier‑2/3 cities to sustain the talent pipeline.
- Monitor and evaluate the impact of the RDI Fund to ensure efficient capital deployment.
- Promote export‑oriented biotech clusters to improve trade balance and global competitiveness.
Collectively, these measures aim to cement India’s position as a leading global biotech hub and achieve the **$300 bn bioeconomy target by 2030**, thereby supporting the nation’s self‑reliant development agenda.